drug

AZD4954

1 story · latest Sep 10, 2026

Status: Investigational
Trials: 3 registered trials in coverage

Relationships

Developed by AstraZeneca

Timeline

AstraZeneca posts CAPItello-281 results in PTEN-deficient prostate cancer; registers AZD4954 Phase 1

Sep 10Weekly roundup, 2 itemsAstraZeneca AZD4954

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.